DGAP-News: HAEMATO AG / Key word(s): Quarter Results/Sales Result HAEMATO AG: Q1 2014: Sales of EUR 53.69 million, net profit of EUR 2.90 million 23.05.2014 / 11:43 --------------------------------------------------------------------- Corporate News of HAEMATO AG: Q1 2014: Sales of EUR 53.69 million, net profit of EUR 2.90 million In the first three months HAEMATO AG, Berlin (ISIN: DE0006190705), achieved IFRS Group sales of EUR 53.69 million (prior-year period: EUR 5.52 million) and net profit for the period of EUR 2.90 million (prior-year period: EUR 2.61 million; thereof from continuing operations EUR 0.16 million; thereof non-recurring profit from discontinued operations EUR 2.45 million). "In the first quarter, HAEMATO Group has increased sales of the continuing pharmaceutical business more than nine fold and has reached a more than eighteen times higher net profit as compared with the prior-year period. The HAEMATO PHARM business, which was only consolidated on April 1, 2013, realised operative growth of about 10 % compared to the same period of the prior year. Due to the results achieved in the first quarter 2014, we are confident concerning the further development for the whole of 2014", says Dr. Cristian Pahl, CEO of HAEMATO AG. About HAEMATO: HAEMATO AG was founded in 1993 and is a stock exchange quoted pharmaceutical company. The company is listed on the Frankfurt Stock Exchange in the Entry Standard (Open Market) and is based in Schönefeld, Germany. The focus of the business activities lies on the growth markets of patent free and patent protected medicinal products. Focal points are therapies with cancer, HIV, cardiovascular and other chronic diseases. Contact: HAEMATO AG, Investor Relations Telefon: +49 (0)30 897 30 86 70 ir@haemato.de End of Corporate News --------------------------------------------------------------------- 23.05.2014 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- 270279 23.05.2014
DGAP-News: HAEMATO AG: Q1 2014: Sales of EUR 53.69 million, net profit of EUR 2.90 million
| Source: EQS Group AG